Gabriele Pollara

• 
  Gabriele Pollara gpollara.bsky.social · 22h
  In vivo gene editing 😲 #MedSky www.nejm.org/doi/full/10....
  

  Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease | NEJM

  Base editors can correct disease-causing genetic variants. After a neonate had received a diagnosis of severe carbamoyl-phosphate synthetase 1 deficiency, a disease with an estimated 50% mortality ...

  nejm.org
  Repost Quote post

  View on BlueskyCopy Bluesky URLCopy post URLTranslate postShow all post labels
• Reposted by Gabriele Pollara
  
  Andre Kalil, MD MPH handle.invalid · May 14
  💥🆕“Guidelines without borders: the case for JAK inhibitors as the first-line immunomodulator COVID-19 treatment” @lancetrespirmed.bsky.social 👇Free Access #IDSky #MedSky #PCCSky #ICUSky #emimcc #Ansky #EMSky #AMSSky #Pharmsky #RXSky #ClinMicro@unmc.bsky.social@unmccom.bsky.social bit.ly/42YLa3y
  

  Guidelines without borders: the case for JAK inhibitors as the first-line immunomodulator COVID-19 treatment

  Identifying safe and effective immunomodulatory therapy for the treatment of infectious diseases has been an elusive pursuit for physician-scientists with mixed clinical results over the past few deca...

  bit.ly
  1

  Repost Quote post

  1

  4

  View on BlueskyCopy Bluesky URLCopy post URLTranslate postShow all post labels
• 
  Gabriele Pollara gpollara.bsky.social · May 13
  Phages as treatment for infections are coming. Lots of steps to get right first though. @cmijournal.bsky.social #IDSky #ClinMicro www.clinicalmicrobiologyandinfection.com/article/S119...
  

  Phages and phage-borne enzymes as new antibacterial agents

  Persistent and resistant infections caused by bacteria are increasing in numbers and pose a treatment challenge to the medical community and public health. However, solutions with new agents that will...

  clinicalmicrobiologyandinfection.com
  Repost Quote post

  2

  3

  View on BlueskyCopy Bluesky URLCopy post URLTranslate postShow all post labels